Gap junction channels are intercellular conduits that allow diffusional exchange of ions, second messengers, and metabolites. Human oligodendrocytes express the gap junction protein connexin47 (Cx47), which is encoded by the GJC2 gene. The autosomal recessive mutation hCx47M283T causes Pelizaeus-Merzbacher–like disease 1 (PMLD1), a progressive leukodystrophy characterized by hypomyelination, retarded motor development, nystagmus, and spasticity. We introduced the human missense mutation into the orthologous position of the mouse Gjc2 gene and inserted the mCx47M282T coding sequence into the mouse genome via homologous recombination in embryonic stem cells. Three-week-old homozygous Cx47M282T mice displayed impaired rotarod performance but unchanged open-field behavior. 10-15-day-old homozygous Cx47M282T and Cx47 null mice revealed a more than 80% reduction in the number of cells participating in glial networks after biocytin injections into oligodendrocytes in sections of corpus callosum. Homozygous expression of mCx47M282T resulted in reduced MBP expression and astrogliosis in the cerebellum of ten-day-old mice which could also be detected in Cx47 null mice of the same age. Three-month-old homozygous Cx47M282T mice exhibited neither altered open-field behavior nor impaired rotarod performance anymore. Adult mCx47M282T expressing mice did not show substantial myelin alterations, but homozygous Cx47M282T mice, additionally deprived of connexin32, which is also expressed in oligodendrocytes, died within six weeks after birth and displayed severe myelin defects accompanied by astrogliosis and activated microglia. These results strongly suggest that PMLD1 is caused by the loss of Cx47 channel function that results in impaired panglial coupling in white matter tissue.
Oligodendrocytes are the myelinating cells of the central nervous system. Together with astrocytes, oligodendrocytes form networks of coupled glial cells—so-called panglial networks—which are built by gap junctions, i.e. intercellular channels composed of connexin proteins. Pelizaeus-Merzbacher–like disease is an inherited early onset myelin disorder of the central nervous system. Certain mutations of the connexin47 gene, which is expressed by oligodendrocytes, cause this disease. Although the course of the human disease is conspicuous and progressive, connexin47 null mice do not show obvious phenotypic alterations suggesting that the disease may be caused by gain of detrimental function due to the connexin47 mutations. Here we introduced a missense mutation that was found in Pelizaeus-Merzbacher–like disease patients into the connexin47 mouse gene. Expression of the mutant connexin47 gene in oligodendrocytes resulted in myelin malformations in young mice but to a relatively mild extent. From a comparison of connexin47 null and connexin47 mutant mice, we conclude that the human Pelizaeus-Merzbacher–like disease is caused by loss of gap junctional coupling, which results in a decreased number of cells coupled within glial networks, and not by a gain of detrimental function of the mutated protein.
Citation: Tress O, Maglione M, Zlomuzica A, May D, Dicke N, Degen J, et al. (2011) Pathologic and Phenotypic Alterations in a Mouse Expressing a Connexin47 Missense Mutation That Causes Pelizaeus-Merzbacher–Like Disease in Humans. PLoS Genet 7(7): e1002146. doi:10.1371/journal.pgen.1002146
Editor: Gregory A. Cox, The Jackson Laboratory, United States of America
Received: November 24, 2010; Accepted: May 1, 2011; Published: July 7, 2011
Copyright: © 2011 Tress et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: OT and MM were supported by a grant (SFB 665 to HK) of the German Research Foundation (www.dfg.de). In addition, work in the Bonn laboratory was supported by a grant of the DFG (Wi270/32-1 to KW). Behavioral analyses were supported by a grant of the DFG (DE1149/4-1 to ED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The autosomal, recessively inherited Pelizaeus-Merzbacher-like disease 1 (PMLD1; MIM: 608804) is an early onset hypomyelinating leukodystrophy caused by mutations in the human connexin47 (Cx47) gene GJC2 (previously called GJA12; MIM: 608803) . Like X-linked Pelizaeus-Merzbacher disease (PMD, MIM: 312080), which is caused by mutations in the gene encoding proteolipid protein 1 (PLP1, MIM: 300401), one of the major proteins in the central nervous system (CNS) myelin, PMLD is characterized by impaired motor development resulting in nystagmus, dysarthria, progressive spasticity and ataxia. First symptoms, nystagmus and poor control of head and trunk movements, occur during early infancy. Twenty-four different mutations including missense, nonsense, partial deletion and frameshift mutations of the GJC2 gene have been reported for PMLD-affected patients to date –. The milder late onset hereditary spastic paraplegia (SPG44, MIM: 613206) is associated with another recessive missense mutation I33M in the GJC2 gene .
All PMLD1 patients are homozygous or compound heterozygous for mutations of the GJC2 gene. Neurological symptoms or MRI abnormalities were not detected in heterozygous individuals – but dominantly inherited lymphedemas (MIM: 613480) were recently described to be associated with GJC2 mutations .
The GJC2 gene encodes the gap junction protein Cx47. Gap junction channels (GJCs) are intercellular conduits for diffusional exchange of ions and small molecules like metabolites and second messengers. Each of the apposed cells contribute per GJC one connexon (hemichannel) which consists of six connexin proteins. Twenty-one human connexins and 20 rodent connexins were described so far which adds to the great theoretical diversity of gap junction channels, since connexons may be composed of one (homomeric) or more than one (heteromeric) connexin isoform. Coupling of connexons consisting of different connexin isoforms is referred to as heterotypic coupling, in contrast to homotypic coupling resulting from GJCs composed of the same connexin isoform. However, the diversity for GJCs is limited because not all heterotypic channels appear to be functional in cultured cells , and different cell types express only few connexin isoforms .
In humans, Cx47 expression was detected in CNS and peripheral nervous system (PNS) , whereas mice express Cx47 (Gjc2; MGI: 2153060) only in oligodendrocytes contributing to gap junctional communication within panglial networks –. Mature oligodendrocytes in the CNS express Cx32 (Gjb1; MGI: 95719) and Cx29 (Gjc3; MGI: 2153041) in addition to Cx47 . Astrocytes express Cx30 (Gjb6; MGI: 107588) and Cx43 (Gja1; MGI: 95713), while Cx26 (Gjb2; MGI: 95720) is expressed in some gray matter astrocytes –. Besides homotypic Cx47/Cx47 channels, heterotypic Cx47/Cx43 and Cx47/Cx30 channels showed functional coupling in cell culture experiments , .
Fracture replica immunogold labeling and immunohistological analyses suggested heterotypic channels between oligodendrocytes and astrocytes (O∶A) forming panglial networks ,  and recent dye transfer experiments on oligodendrocytes in the corpus callosum confirmed O∶A intercellular communication. In addition, these experiments revealed functional interoligodendrocytic (O∶O) coupling. Both, O∶O and O∶A coupling were significantly affected in Cx47 deficient mice suggesting a crucial role for Cx47 gap junctions in panglial networks . Accordingly, Cx47 deficient mice showed myelin vacuoles but behavioral or further anatomical abnormalities have not been observed as yet . Mutations in the GJB1 (MIM: 304040) gene coding for hCx32 protein result in the demyelinating peripheral neuropathy X-linked Charcot-Marie-Tooth disease (CMTX, MIM: 302800). Cx32 deficient mice showed only mild, late onset myelination deficits in the CNS  but additional deletion of Cx32 in Cx47 deficient mice results in severe myelin abnormalities and premature death. This indicates some functional redundance of these connexins expressed by oligodendrocytes.
Since Cx47 null mice show only mild myelin abnormalities, in contrast to human PMLD patients, we generated a mouse model for PMLD by knock-in of the point mutation mCx47M282T into the endogenous Cx47 gene locus. The orthologous human missense mutation hCx47M283T was found homozygously in PMLD patients .
The Cx47M282T expressing mice enabled us to investigate whether loss of Cx47 function regarding O∶O and O∶A coupling, a transdominant effect on Cx32 or gain of detrimental function by intracellular effects of the mutant Cx47 contribute to the disease.
Young homozygous Cx47M282T expressing mice showed impaired motor coordination and balancing performance on the accelerating rotarod, decreased punctate Cx47 immunostaining and similar to Cx47 deficient mice, diminished O∶O coupling in the corpus callosum, compared to wildtype mice. Furthermore, like Cx47 deficient mice, homozygous Cx47M282T mice revealed retarded myelin formation during the first weeks after birth.
Similar to Cx47/Cx32 null mice, homozygous Cx47M282T mice deprived of Cx32 showed severe myelin abnormalities and died within the first four months after birth, demonstrating an essential function and partial redundancy of both connexin isoforms for maintenance of mouse myelin.
Our results indicate that loss of Cx47 function in GJC leads to myelin pathology in juvenile mice which can to a large extent be compensated during subsequent development to adulthood.
Generation of Cx47M282T Mice
The mCx47M282T mutation was generated by PCR mutagenesis using purified genomic DNA obtained from a C57BL/6 mouse as template. Codon 282 was mutated to cause a methionine residue to threonine transition by T to C exchange at nucleotide 845 of the mCx47 coding region which in addition resulted in a recognition site (5′-(N)5GAGACG-3′) of the restriction endonuclease BsmBI. We replaced the mouse Cx47 coding region by the mutated mCx47M282T one, an internal ribosome entry site (IRES) followed by the Escherichia coli β-galactosidase (β-gal) coding DNA (LacZ), preceded by a nuclear localization sequence and a frt-site-flanked neomycin selection cassette by homologous recombination in HM-1 embryonic stem cells  (Figure 1A). Twenty-four of 377 neomycin resistant clones were positively characterized for homologous recombination by two individual PCRs. Homologous recombination was further verified by Southern blot analysis. Three of the targeted ES cell clones were microinjected into C57BL/6 blastocysts. Two clones yielded germline transmission chimeric mice that produced heterozygous Cx47+/M282Tneo offspring after backcrossing with C57BL/6 mice. The frt-site-flanked neomycin resistance cassette was deleted by mating of Cx47+/M282Tneo mice to hACTB:FLPe mice  which yielded the offspring Cx47+/M282T deprived of the neomycin selection cassette (Figure 1B). All mice further investigated harboured at least 96% of C57BL/6 genetic background. Mice carrying the mutant mCx47M282T allele heterozygously (Cx47+/M282T and Cx47+/M282Tneo) were interbred to obtain Cx47+/+, Cx47+/M282T and Cx47M282T/M282T or Cx47+/+, Cx47+/M282Tneo and Cx47M282T/M282Tneo offspring, respectively. Genotypes were demonstrated by PCR (Figure 1C and E) and Southern Blot (Figure 1F) analysis. Genomic presence of the mutated mCx47M282T was analyzed by PCR and subsequent BsmBI digestion (Figure 1D). Female as well as male Cx47+/M282T and Cx47M282T/M282T mice were fertile.
A, Scheme of homologous recombination of the targeting vector into the Cx47 coding region. The resulting transgenic allele (Cx47M282Tneo) includes mCx47M282T coding DNA, an internal ribosome entry site (IRES) followed by a nuclear localization signal (nls) fused to LacZ coding DNA and a neomycin selection cassette flanked by frt-sites. The endonuclease BsmBI restriction site was generated by T to C transition on nucleotide 845 of the Gjc2 coding region, resulting in the mutant mCx47M282T. B, Flp recombinase activity causes deletion of the neomycin selection cassette. Specific primer binding sites and MfeI restriction sites are indicated. C, PCR products specific for wild-type (570 bp) and transgenic loci (730 bp) using DNA obtained from tail tip tissue. D, Presence of the mutant allele was proven by PCR amplification of a 700 bp Cx47 fragment and subsequent BsmBI digestion. Only mutant alleles yielded the 350 bp fragment. E, PCR analysis resulted in amplification of the 1,700 bp fragment of the neomycin selection cassette deprived allele and the 450 bp fragment of the Cx47M282Tneo locus. F, Homologous recombination and different allelic combinations were confirmed by Southern blot hybridization using a probe derived from the 3′ region of Cx47. MfeI digestion of genomic DNA prepared from liver resulted in the of 4.6 kb fragment for the Cx47 wildtype allele, the 10.5 kb fragment for the Cx47M282Tneo allele and the 8.5 kb fragment for the Cx47M282T allele.
mCx47M282T and LacZ Reporter Gene Expression
Expression of the mutant mCx47M282T gene in transgenic animals resulted in a bicistronic mRNA coding for mCx47M282T and the reporter LacZ DNA. The β-gal encoded by LacZ DNA featured a nuclear localization signal and was detected by X-Gal and antibody staining. Translation of the LacZ mRNA was mediated by an IRES cassette. To further characterize LacZ expression, immunohistochemical analyses of cell type specific markers were combined with X-Gal staining. The reporter LacZ DNA was expressed in Cx47-positive cells (Figure 2E) and was coexpressed with the oligodendrocytic marker protein 2′,3′-cyclic nucleotide 3′ phosphodiesterase (CNPase) (Figure 2A). X-Gal staining was not colocalized with immunohistochemical signals of the neuronal marker (NeuN) or the astrocytic marker (GFAP) (Figure 2B and 2C). Immunofluorescence analyses showed a marked decrease of Cx47-positive puncta in Cx47M282T/M282T and, although less pronounced, in Cx47+/M282T brain slices compared to wildtype. Furthermore, Cx47 immunostaining revealed that the mCx47M282T protein does not exhibit the typical gap junctional immunosignals at oligodendrocytic somata . β-Gal signals were obvious in Cx47+/M282T and Cx47M282T/M282T but absent in wildtype brain tissue (Figure 2D–2F). Immunoblot analysis of β-gal in brain lysates obtained from P40 mice yielded distinct signals in Cx47+/M282T and Cx47M282T/M282T around 120 kDa but not in corresponding wildtype controls (Figure 2G). Immunoprecipitation (IP) and subsequent immunoblot analysis against Cx47 revealed bands on wildtype and Cx47M282T/M282T brain lysates around 50 kDa. No signals were found in Cx47 deficient (Cx47−/−) control lysates after IP but immunoblot analysis on crude Cx47−/− whole brain lysates yielded false positive signals for all genotypes at approximately 50 kDa. To minimize precipitation and subsequent detection of cross reacting proteins, IPs and immunoblots were conducted using two distinct Cx47 antibodies (Zymed No. 37-4500 and Zymed No. 36-4700). HeLa cell control lysates yielded signals for the transfected Cx47-eGFP fusion protein around 75 kDa with crude lysates and after IP indicating accuracy of the procedure. Signals around 40 kDa in this lane are probably caused by the cleaved Cx47 C-terminus, since antibodies used were directed against peptides derived from the C-terminal region of Cx47.
A–C, LacZ staining of 50 µm brain slices obtained from Cx47+/M282T mice. The β-gal activity is restricted to nuclear localisation. A, β-Gal positive cells in the corpus callosum show typical oligodendrocytic chain-like organization and coexpression of the oligodendrocytic marker CNPase. LacZ expression was not detectable in GFAP-positive astrocytes (B) or NeuN-positive neurons (C). D, Immunostaining with Cx47 antibodies (green) revealed signals in close proximity of Syto-61 stained nuclei in the corpus callosum of Cx47+/+ mice. Weaker signals were also found more distal to the nuclei. E, Cx47 antibody stainings on heterozygous Cx47+/M282T mice resulted in weaker, but similarly localized immunosignals compared to those obtained on wildtype brain tissue. Cx47 gap junction immunosignals were predominantly localized close to β-gal positive nuclei indicated by antibody staining. F, Homozygous Cx47M282T/M282T mice showed apparent β-gal immunoreactivity, but robust Cx47 gap junction immunosignals were not detected in the perikarya. Very weak Cx47 signals were noticed in brain tissue of Cx47M282T/M282T mice. G, Immunoblot staining against β-gal on whole brain lysates of 40-day-old mice yielded strong signals with Cx47M282T/M282T, weaker signals with Cx47+/M282T and no signals with Cx47+/+ tissue. H, Immunoblot analysis on Cx47 protein resulted in unspecific bands at 50 kDa of whole brain lysates obtained from wildtype, Cx47M282T/M282T and Cx47 deleted (Cx47−/−) tissue. Immunoprecipitated Cx47 was detected in wildtype and Cx47M282T/M282T tissue. Lysates of Cx47-eGFP fusion protein expressing HeLa cells yielded signals at 75 kDa as expected and additional weaker signals at approximately 40 kDa after immunoprecipitation of Cx47 and with crude HeLa cell lysate. Additional signals at 40 kDa in these lanes may represent the cleaved C-terminal region of Cx47. Scale bars: A–C, 50 µm; D–F, 20 µm.
mCx47M282T Mice Show Characteristc Distribution Patterns of Oligodendrocytes during Postnatal Brain Development
An increase of β-gal positive cells in CNS white and gray matter of Cx47M282T/M282T mice (Figure 3) and Cx47+/M282T (not shown) was observed during postnatal development (P7–P105). At P7 β-gal positive cells were detected in the cerebellar white matter (Figure 3A), less in corpus callosum and in fimbria of hippocampus and only few isolated cells in the cerebral cortex (Figure 3E). At P10 the number of β-gal positive cells abundantly increased in the corpus callosum and the hippocampal fimbria. Unlike P7 mice, P10 animals displayed scattered β-gal positive cells localized in layer VI of the cerebral cortex (Figure 3F), whereas few β-gal positive cells were found in the cerebellar granular layer (Figure 3B). At P16 β-gal positive nuclei increased more than twofold in the cerebellar white matter and granular layer compared to P10 mice (Figure 3B and C). At this developmental stage, we also observed β-gal positive cells in the hippocampus, predominantly localized at the hippocampal fissure and alveus, and in layers VI-IV of the cerebral cortex, while the number of LacZ expressing cells in white matter tracts was further increased (Figure 3G). After 3.5 months of postnatal development (P105) the number of β-gal positive cells was increased in white matter and adjacent gray matter compared to P16 mice (Figure 3D). X-Gal stained nuclei were furthermore present in all layers of the cerebral cortex, decreasing in number from layer VI to layer I. Isolated β-gal positive cells were found widespread over the hippocampal gray matter (Figure 3H). In cerebellar and cerebral white matter of P105 mice LacZ expressing cells were often organized in a chain-like structure parallel to the direction of the fibers, as typically observed for oligodendrocytes in white matter (Figure 3D and 3H).
Sagittal 50 µm brain sections were X-Gal stained for LacZ expression and counterstained with eosin. The LacZ reporter gene reflects the expression of Cx47. A, In the cerebellum of 7-day-old Cx47M282T/M282T mice several X-Gal stained oligodendrocytes were already found in the medullary centre. B, Stainings on cerebella of P10 mice revealed an increase in the number of β-gal positive cells in the white matter compared to P7 mice. Single β-gal positive cells were already found in the granular layer. C and D, Cx47 expressing cells further increased in number during development of the cerebellum. In addition to their localisation in the cerebellar white matter, LacZ expressing cells were found to be widespread among the granular layer in the cerebellum of 105 day old mice. E, Compared to the number of X-Gal stained cells in the white matter of P7 cerebellum, only few cells were stained in P7 cerebral white matter, localized in the corpus callosum and the hippocampal fimbria. Single cells were found in the cortex proximal to the corpus callosum. The hippocampal gray matter was almost free of β-gal positive cells at this developmental stage. F, On P10 the number of X-Gal stained cells was remarkably increased in the corpus callosum and the hippocampal fimbria compared to P7. β-Gal positive cells decreased in number from ventral to dorsal in the corpus callosum to the cortex. G, P16 animals showed robust LacZ expression in the white matter of the cerebrum including corpus callosum, hippocampal fimbria and hippocampal alveus. Furthermore, β-gal positive cells were present at the hippocampal fissure and near the hippocampal regions Cornu ammonis 1 (CA1) and CA3. Compared to P10 the number of LacZ expressing cells increased dramatically in cortical layers VI to IV of P16 mice. H, 105 days after birth Cx47 expressing cells represented by LacZ reporter gene stainings were localized all over the telencephalon with strong accumulation and typical oligodendrocytic chain-like organizaiton in the white matter. In gray matter, β-gal positive cells were scatterly distributed with a decreasing gradient ranging from layers VI to I of the neocortex. Scale bar: A–H, 500 µm.
Neuropathologic Abnormalities in Juvenile Cx47M282T/M282T Mice
Sixteen day-old Cx47M282T/M282T mice featured a neuropathologic phenotype affecting mainly the white matter in some regions of the CNS (Figure 4). Within the cerebellar white matter, cystic spaces of about 100 µm diameter were found, filled with cellular debris, sometimes featuring an onion shell – like lamellar pattern. Within the cerebellar gray matter, scattered groups of mainly Purkinje neurons could be seen at different stages of degeneration.
Semi-thin sections of cerebellar white matter of Cx47+/+ (A, C) Cx47+/M282T (B, E, I) and Cx47M282T/M282T (C, F, G, J) mice are shown after staining with toluidine blue/pyronin g. Cystic spaces in white matter are indicated by asterisks in C and can be delineated from blood vessels (BV) due to their irregular lining and absence of endothelia. At higher magnification (F, G) cysts can be shown to contain cellular debris (arrows in G). No alterations were seen in cerebella from heterozygous mice (B, E). In the prechiasmatic optic fascicle of Cx47M282T/M282T mice, similar cysts are evident (arrows in J, compared to blood vessles (BV) in the WT control shown in H). Scale bars: A–C, 50 µm; D–J, 20 µm.
A similar cystic degeneration of CNS white matter was observed in the prechiasmatic optic fascicle featuring about 2–3 cysts of about 100 µm diameter per cross section.
Interestingly, while the effects in cerebellum and optic fascicle were rather constant between different experimental animals, the effects of mCx47M282T expression in the remainder of the telencephalon were much more variable. Most notably, the main white matter tracts like fimbria hippocampi, corpus callosum or anterior commissure did not show any regularly occurring cystic degeneration. Within the gray matter, we inconstantly observed groups of degenerating cells in the hippocampal field CA1 and in the subgranular zone of the dentate gyrus (Figure S1A and S1B).
Next to the neuronal damage, we inconstantly observed cell debris and degenerating small cells at the outer aspect of numerous brain capillaries, indicative of a disseminated, and again highly variable destruction of perivascular astroglia (Figure S1C–S1E).
In heterozygous mice, the morphology of the cerebellum was essentially normal (Figure 4B, E): likewise, lesions within the optic fascicle were almost absent except for a small number (about 2 per cross section of one fascicle) of individual cells being swollen and degenerated (Figure 4I).
We investigated general activity, motor coordination and motor learning performance in juvenile (23 days old) and adult (three months old) mCx47M282T mice. Since PMLD is caused by an autosomal recessive mutation we also investigated whether heterozygous mice would exhibit an intermediate phenotype ranging between homozygous and wild-type mice. For this purpose pre-planned pair-wise comparisons between wild-type mice and homozygous as well as between wild-type mice and heterozygous mice were performed.
Open-field behavior of juvenile mice.
Across the three trials in the open-field, the animals, irrespective of genotype, showed significant reductions in the distance moved (main effect of trials: p<0.001; repeated measures ANOVA; Figure 5A), running speed (p<0.001; Figure 5C), as well as in the number (p<0.001; Figure 5E) and duration of rearings (p<0.001; Figure 5G). However, there were no significant main effects of genotype for the variables distance moved, running speed, or the number and duration of rearings (all p's>0.05). Except for the distance moved parameter (genotype×trial interaction: p = 0.036), the genotype × trial interactions for the remaining parameters were all not significant (all p's>0.05). Interestingly, the analysis of the rearing behavior (number and duration) during the second trial yielded an unexpected genotype distribution. On the second trial, the Cx47+/+ mice exhibited an intermediate level of rearing activity, while the Cx47+/M282T showed higher and the Cx47M282T/M282T mice the lower rearing activity as compared to controls. Indeed, Student t-test comparisons between Cx47+/M282T and Cx47M282T/M282T mice for single trials revealed a significant difference in the number (p = 0.02) and duration of rearings (p = 0.0154) during trial 2 but not during the trials 1 and 3. There were no significant differences in terms of rearing behavior on trials 1–3 between the Cx47M282T/M282T or Cx47+/M282T and the Cx47+/+ mice (all p's>0.05). In repeated (ANOVA treated) measurements of the behavioral parameters, no main effects of genotype were detected. These results suggest that expression of the mCx47M282T mutation has no detrimental effects on open-field behavior in juvenile mice.
A and B, Circles represent mean ± sem locomotion (distance moved in cm) on indicated trials. C and D, Circles represent mean ± sem running speed (in cm/s) on indicated trials. E and F, Circles represent mean ± sem number of rearings on indicated trials. G and H, Circles represent mean ± sem duration of rearings (in s) on indicated trials. I and J, Motor coordination and balancing on the accelerating rotarod. Circles represent mean ± sem time of active performance (in s) on acquisition and retention trials. ***: Cx47+/+ versus Cx47M282T/M282T, p = 0.01; Bonferroni test. *: Cx47+/+ versus Cx47+/M282T, p = 0.01; Bonferroni test.
Open-field behavior of adult mice.
Across the three exposures to the open-field, the animals showed significant decrements in the distance moved (main effect of trials: p<0.001; repeated measures ANOVA; Figure 5B), running speed (p<0.001; Figure 5D), and duration of rearings (p = 0.042; Figure 5H), but not in the number of rearings (p>0.05; Figure 5F). The open-field behavior of the three groups was significantly different. The groups differed in terms of the distance moved (main effect of genotype: p = 0.002; repeated measures ANOVA; Figure 5B), running speed (p = 0.002; Figure 5D), as well as regarding the number (p = 0.001; Figure 5F) and duration (p = 0.003; Figure 5H) of rearings. Post-hoc pair-wise comparisons revealed that compared to Cx47+/+ control mice, the Cx47+/M282T mice showed significantly reduced locomotion (p = 0.002; Bonferroni test), running speed (p = 0.002) and rearing activity (number: p = 0.001; duration: p = 0.002). The Cx47+/+ mice also showed higher levels of open-field activity relative to the Cx47M282T/M282T. However, these differences failed to reach the predetermined level of statistical significance (p's>0.05). These results suggest that the heterozygous expression of the mCx47M282T mutation in the adult mouse impairs open-field behavior.
Motor coordination and balancing performance of juvenile mice.
The animals performance improved across the nine acquisition trials (main effect of trials; p<0.001; repeated measures ANOVA, Figure 5I). There were no significant main effects of genotype (p = 0.097) or genotype×trial interaction (p = 0.093). However, the p-values indicated trends towards significance. Pre-planned pair-wise comparisons revealed that compared to Cx47+/+ control mice, Cx47M282T/M282T mice showed significantly impaired rotarod performance during the acquisition stage of the task (main effects of genotype: p = 0.016). Cx47+/+ mice also outperformed heterozygous Cx47+/M282T mice. However, this difference failed to reach the predetermined level of statistical significance (p>0.05). In contrast, there were no significant differences between groups during the retention test (p's>0.05). These results suggest that the homozygous expression of the mCx47M282T mutation in juvenile mice has a detrimental effect on the acquisition of the rotarod task.
Motor coordination and balancing performance of adult mice.
The animals performance improved across the nine acquisition trials (main effect of trials; P<0.001; repeated measures ANOVA, Figure 5J). However, there were no significant main effects of genotype or genotype×trial interaction (p's>0.05). Similarly there were no significant main effects of genotype or genotype × trial interaction or pre-planned pair-wise comparisons (p's>0.05) during the retention phase. Pre-planned pair-wise comparisons between Cx47+/+ control and Cx47M282T/M282T as well as between Cx47+/+ control Cx47+/M282T mice revealed no significant differences (p's>0.05). These results show that the mCx47M282T mutation has no effect on rotarod performance in the adult mouse.
Taken together, three-week-old homozygous Cx47M282T expressing mice showed impaired motor coordination and balancing performance on the accelerating rotarod. Three-month-old homozygous Cx47M282T mice had compensated the rotarod impairment caused by mutant Cx47 expression. Compared to wildtype controls, three-week-old homozygous and heterozygous Cx47M282T expressing mice showed normal behavior in the open-field, while three-month-old heterozygous Cx47M282T mice exhibited reduced motor activity in the open-field.
mCx47M282T Mutation Reduces Oligodendrocyte Coupling
To address the question whether homozygous and heterozygous expression of mCx47M282T mutation affects coupling, dye transfer experiments were performed in the corpus callosum of acute coronal slices obtained from P10–15 mice. In each slice, single oligodendrocytes were dialyzed by whole cell patch-clamp with the gap junction permeable tracer biocytin, as previously described . Membrane currents of the injected oligodendrocyte were recorded in response to a series of hyperpolarizing and depolarizing voltage steps (10 mV increment) from −170 mV to +50 mV for 50 ms (Figure 6A1, 6B1). The cohort of wildtype and Cx47−/− control mice was the same as previously published, since the experiments reported here were done in parallel with the former study .
A1 and B1, Membrane currents of oligodendrocytes were recorded in response to a series of voltage steps ranging from −170 and + 50 mV (50 ms, 10 mV increments) from a holding potential of −70 mV. A2 and B2, Oligodendrocytes were identified by their typical morphology as revealed by dialysis with the fluorescent dye Alexa 594. A3 and B3, Superpositions of sequential confocal stacks indicating biocytin/streptavidin-Cy3 labeled networks. C–E, Quantification of networks in homozygous and heterozygous mCx47M282T as well as Cx47−/− mice compared to wildtype animals. C, Percentage of injected cells which were coupled to at least one other cell and thereby formed a network (dark gray) versus injected uncoupled cells (light gray). Note that in Cx47+/M282T mice only 27% of injected oligodendrocytes were found to be coupled. Asterisks indicate statistical significance (Chi Square Test, *** p<0.001). D, Boxplot indicating median (dark line), 25th and 75th percentiles (upper and lower hinges, respectively) of the number of coupled cells per network in Cx47M282T/M282T and Cx47+/M282T compared to wildtype mice. Similarly to Cx47−/− mice, Cx47M282T/M282T animals displayed a significant reduction in the number of cells participating in the oligodendrocytic network (6%; 4%–13%; Kruskal-Wallis test, p = 0.001, Mann-Whitney U-test, *** p<0.001). E, Extent of tracer spread as defined by the largest distance between two somata within the coupled network. No significant difference was observed between homozygous and heterozygous mCx47M282T mice compared to wildtype animals. In Cx47−/− mice, the extent of tracer spread was significantly reduced compared to wildtype animals (132±11 average, One way ANOVA p<0.05, Bonferroni post hoc test, p<0.05).
We distinguished between oligodendrocytes participating in glial networks and uncoupled oligodendrocytes by biocytin injection into oligodendrocytes and subsequent streptavidin-Cy3 labeling (Figure 6C). The number of coupled cells and extent of tracer spread (µm) were determined for the networks identified (Figure 6D, 6E) and glial cells whithin these networks were further characterized by marker protein costainings (Figure 7). For a detailed numeric representation see Table 1.
A1–A5, Example of cell-type identification in biocytin labeled networks of Cx47M282T/M282T mice. Biocytin was detected with streptavidin-Cy3 (A1) and oligodendrocytes were identified by CNPase immunostaining (A2). A3, Immunolabeling of the same section for the astrocytic marker GFAP. A4, Overlay of A1 and A2. A5, Overlay of A1 and A3. In this network no coupled cell expressed GFAP. B1–B5, Biocytin labeling with streptavidin-Cy3 (B1) combined with immunostaining for CNPase (B2) and GFAP (B3) in the corpus callosum of Cx47+/M282T mice. B4, Overlay of B1 and B2. B5, Overlay of B1 and B3. Note the GFAP-positive astrocyte (asterisk) labeled with biocytin. The same cell was CNPase-negative (B4, asterisk). C, Boxplot indicating median (dark line), 25th and 75th percentiles (upper and lower hinges, respectively) of the population of cells coupled within networks. Values of specific glial cell types are given as percentage of the number of biocytin-positve cells per network. In both Cx47M282T/M282T and Cx47+/M282T mice the majority of coupled cells were CNPase-positive, a small population lacked immunopositive signals for both CNPase and GFAP, and few GFAP-positive cells were found. Cx47+/M282T expression in comparison to wildtype tissue did not result in significant differences regarding the population of coupled cells per network. In Cx47M282T/M282T mice, immunostaining revealed an increased amount of CNPase-positive cells in the panglial networks (100%; 86%–100%; Kruskal-Wallis test, p<0.01, Mann-Whitney U-test, **p<0.01). A significantly diminished number of cells negative for both CNPase and GFAP were detected in these networks (0%; 0%–7%; Kruskal-Wallis test, p<0.01, Mann-Whitney U-test, *p<0.05). In Cx47−/− mice all coupled cells were identified as eGFP-positive, i.e. oligodendrocyes . No significant difference in oligodendrocyte-to-oligodendrocyte or oligodendrocyte-to-astrocytel coupling between Cx47M282T/M282T and Cx47+/M282T mice was observed.
In Cx47M282T/M282T mice, 67% of the single oligodendrocytes dialyzed with biocytin formed networks (10 out of 15 slices from 3 mice). In these ten networks the median value of biocytin-positive (coupled) cells was 6 (4–13; values indicate 25th–75th percentiles, respectively), with a significant reduction by 88% in the number of coupled cells per network as compared to wildtype mice (Kruskal-Wallis, p = 0.001, Mann-Whitney U-test, p<0.001). Measuring the largest distance between two cells within a network indicated that the mean extent of tracer spread for Cx47M282T/M282T mice compared to wildtype animals was not significantly different (Figure 6C–6E).
To determine whether homozygous mCx47M282T expression affected coupling of oligodendrocytes to neighboring oligodendrocytes and astrocytes, biocytin/streptavidin-Cy3 labelling was combined with immunostaining for the oligodendrocytic marker CNPase and the astrocytic marker GFAP. In Cx47M282T/M282T mice the majority of biocytin-positive cells coupled within a given network were CNPase-positive (100%; 86%–100%), with a significant increase in comparison to wildtype (see table 1; Kruskal-Wallis, p<0.01, Mann-Whitney U-test, p<0.01) (Figure 7A and 7C). GFAP-positive cells colabeled with biocytin/streptavidin-Cy3 (0%; 0%–6%) were found only in 3 out of ten networks (Figure 7A and C). However, the observed reduction was not significant compared to wildtype mice (see Table 1). Within a network analyzed we detected a population of CNPase- and GFAP-negative cells, which was significantly reduced to a median value of 0% (0%–7%) compared to wildtype animals (see table 1; Kruskal-Wallis p<0.05, Mann-Whitney U-test, p<0.01) (Figure 7A and 7C).
In heterozygous Cx47+/M282T mice (Figure 6B1–6B3) only 4 out of 15 biocytin injections into single oligodendrocytes revealed intercellular coupling (27% formed networks, 4 mice), with networks consisting of a median value of 36 cells (6–82) and tracer spreading up to 193 µm (average 131±24 µm) (Figure 6). The observed decrease in the number of oligodendrocytes forming networks was significantly different in comparison to wildtype mice (see table 1; Chi-Square Test, Chi Square = 12.523, p<0.001) . However, the number of coupled cells within a given panglial network and the extent of biocytin spread were not significantly affected as compared to wildtype animals . Similar to the networks detected in brain slices obtained from wildtype mice, the majority of biocytin-positive cells were CNPase-positive, 3% (0%–7%) coupled cells were CNPase- and GFAP-negative, while the remaining 11% (1%–18%) were GFAP-positive astrocytes (Figure 7B and 7C).
Thus, homozygous mCx47M282T expression resulted in a decrease in the number of coupled cells within the network of cells coupled to the injected oligodendrocyte. No significant difference in number of coupled cells between Cx47M282T/M282T and Cx47−/− mice was observed. Heterotypic coupling of oligodendrocytes to GFAP-positive astrocytes was impaired but not completely abolished and coupling to the population of CNPase- and GFAP-negative cells was significantly affected. Heterozygous mCx47M282T expression caused a decrease by 68% in the number of oligodendrocytes forming networks in comparison to wildtype animals, but did not impair the number of coupled cells within a given network. However, in Cx47+/M282T mice neither the number of coupled cells within a network nor coupling of oligodendrocytes to astrocytes and to the subpopulation of CNPase- and GFAP-negative cells was significantly affected.
Developing Cerebella of Cx47M282T/M282T, Cx47+/M282T, and Cx47 null Mice Show Retarded Myelin Formation, Astrogliosis, As Well As Increased Iba1 Expression
In cerebellar slices obtained from P10 Cx47M282T/M282T and Cx47−/− mice vacuoles were occasionally present in the white matter tract and MBP stainings appeared inhomogeneous compared to wildtype and cerebella of Cx47+/M282T mice. Furthermore, Cx47M282T/M282T and Cx47−/− mice showed fewer fine fibers in the granular layer than wildtype littermates and these fibers did not reach the Purkinje cell layer in Cx47+/M282T, Cx47M282T/M282T and Cx47−/− as observed in Cx47+/+ slices (Figure 8A, 8D, 8G and 8J). Expression of the mCx47M282T protein resulted in conspicuous astrogliosis in the cerebellar white matter of Cx47M282T/M282T and Cx47−/− animals as indicated by up-regulation of GFAP expression, while Cx47+/M282T mice displayed only a mild increase in GFAP levels within white matter tracts (arrows). Furthermore, fewer GFAP-positive cells were visible in the cerebellar granular layer of Cx47M282T/M282T mice (Figure 8B, 8E, 8H and 8K). Elevated ionized calcium-binding adapter molecule 1 (Iba1) expression indicated accumulation/activation of microglial cells in the cerebellar white matter of Cx47+/M282T, Cx47M282T/M282T and Cx47−/− animals (Figure 8C, F, I and L). However, astrogliosis and activation of microglial cells could not be detected any longer in P90 Cx47+/M282T and Cx47M282T/M282T mice (Figure 9E, H, F and I). In the cerebellar granular layer of 3-month-old Cx47M282T/M282T mice, GFAP-positive cells were still diminished compared to corresponding Cx47+/M282T and Cx47+/+ mice (Figure 9B, F and H). MBP staining on cerebella slices of adult Cx47M282T/M282T mice revealed uneven signals in the white matter compared to wildtype littermates. Vacuoles could not be detected anymore but the fine myelin fibers pervading the granular layer were almost absent in cerebella of Cx47+/M282T and Cx47M282T/M282T mice (Figure 9A, 9D and 9G).
A, D, G and J, Immunohistochemical analysis on 25 µm sagittal brain slices obtained from 10-day-old animals revealed fewer myelinated, MBP-positive fine fibers pervading the cerebellar granular layer of Cx47+/M282T, Cx47M282T/M282T and Cx47−/− mice compared to Cx47+/+ littermates. B, E, H and K, Delayed myelin formation is accompanied by elevated GFAP expression, indicating astrogliosis in the cerebellar white matter which appeared minor in Cx47+/M282T tissue but was pronounced in cerebella of P10 Cx47M282T/M282T and Cx47−/− mice. Arrows indicate the transition of white matter to the granule cell layer. Compared to wildtype tissue fewer GFAP-positive cells were localized in the granular layer of Cx47M282T/M282 cerebella. Note the GFAP-positive radial processes of Bergmann glia cells pervading the molecular layer. Signals of GFAP-positive Begmann glia processes were used as internal control for staining intensities. C, F, I and L, Microglia were constantly distributed throughout the whole brain. Activated microglia displayed increased levels of Iba1. In P10 cerebella microglia with elevated Iba1 expression were found to a greater extent in brain slices obtained from Cx47+/M282T, Cx47M282T/M282T and Cx47−/− animals relative to Cx47+/+ tissue. Auxiliary lines (MBP and Iba1 stainings) indicate the granular and Purkinje layer transition. Scale bars: A–L, 200 µm; insets, 50 µm.
Additional deletion of Cx32 in homozygous mCx47M282T expressing mice resulted in severe myelin malformation, astrogliosis and microglia activation. A, Immunohistochemical analysis on 25 µm sagittal cerebellar slices obtained from 90-day-old animals yielded strong myelin staining in the granular layer of wildtype mice. D, G and J, Only few MBP-positive fibers attaining the Purkinje cell layer were found in corresponding regions of Cx47+/M282T, Cx47M282T/M282T and Cx47+/M282T/Cx32Y/− mice. M, MBP immunohistochemical signals were very weak in Cx47M282T/M282T/Cx32Y/− animals and appeared like debris in the granular layer. B, E, H, K and N, GFAP stainig on cerebellar slices of all five genotypes revealed astrogliosis only in Cx47M282T/M282T/Cx32Y/− animals (N) whereas Cx47+/+, Cx47+/M282T, Cx47M282T/M282T and Cx47+/M282T/Cx32Y/− mice did not display increased GFAP expression in the cerebellar white matter. H inset, Like P10 mice (Figure 8H), adult Cx47M282T/M282T mice harboured fewer GFAP-positive cells in the granular layer compared to Cx47+/+ and Cx47+/M282T mice. Arrows indicate the transition of white matter to the granule cell layer. Signals of GFAP-positive Begmann glia processes were used as internal control for staining intensities. O, Furthermore, considerable numbers of Iba1 expressing activated microglial cells were present in Cx47M282T/M282T/Cx32Y/− cerebellar white matter. All other genotypes investigated did not display microglia with increased Iba1 exression in cerebellar tissue. Auxiliary lines indicate the granular and Purkinje cell layer transition. Scale bars: A–O, 200 µm; insets MBP and GFAP stainings, 50 µm; insets Iba1 stainings, 25 µm.
Oligodendrocytic Myelin Protein Synthesis Is Impaired in mCx47M282T-Expressing Mice
To ascertain the impact of mCx47M282T on oligodendrocyte differentiation, we examined the expression of the early oligodendrocyte marker 2′,3′-cyclic nucleotide 3′ phosphodiesterase (CNPase) and the marker for mature myelinating oligodendrocytes myelin basic protein (MBP)  at five stages (P10–P90) of postnatal development (Figure 10).
Immunoblots were performed with cerebellar lysates. At least three animals per group were analyzed. For each oligodendrocytic marker, protein levels were normalized to β-tubulin expression as internal standard. Expression levels of Cx47+/+ mice were set to 100% per group. A, Densitometric quantification of immunoblot analyses revealed significantly decreased CNPase expression in P10, P16 and P40 Cx47M282T/M282T mice compared to their wildtype littermates (** p<0,05; *** p<0,001; ANOVA). Cx47+/M282T mice showed a significant reduction of CNPase expression on P16 in comparison to Cx47+/+ animals. However, at an age of 90 days both Cx47M282T/M282T and Cx47+/M282T mice displayed significantly higher CNPase expression levels compared to Cx47+/+ littermates. Similarly, 90-day-old homozygous mCx47M282T expressing mice additionally deficient for Cx32 (Cx47M282T/M282T/Cx32Y/−), displayed significantly increased CNPase levels in immunoblot analysis. B, Relative CNPase expression in Cx47+/+ mice during postnatal development was determined via densitometric analysis of immunoblots. CNPase quantification analyses (A) showed the development-dependent expression of CNPase in cerebella of Cx47+/+, Cx47+/M282T and Cx47M282T/M282T mice. In the cerebellum, Cx47+/+ mice displayed an expression peak of CNPase around P40, while the CNPase levels in Cx47+/M282T and Cx47M282T/M282T cerebellar tissue augmented on P90 of postnatal development. C and D, Analogous illustration of MBP expression: C, At each developmental stage, MBP levels in Cx47+/M282T and Cx47M282T/M282T cerebella were normalized to the MBP expression level of Cx47+/+ animals (100%). In Cx47+/M282T and Cx47M282T/M282T cerebella a significant MBP reduction was observed between P10 and P40 compared to wildtype littermates, with strongest impact on P10. Three-month-old Cx47M282T/M282T mice did not show significantly altered MBP expression any longer, while MBP signals were significantly enhanced in Cx47+/M282T mice on P90. Immunoblots on lysates obtained from P90 Cx47M282T/M282T/Cx32Y/− mice revealed a clear reduction of MBP expression. D, Development-dependent MBP expression illustrates early hypomyelination and compensation during adolescence in Cx47+/M282T and Cx47M282T/M282T animals. Error bars indicate SEM. E, Representative immunoblot analyses on cerebellar tissue obtained from Cx47+/+, Cx47+/M282T and Cx47M282T/M282T mice during postnatal development (40 µg proteins/lane). Cx47M282T/M282T/Cx32Y/− animals analyzed on P90 exhibited disorders during movement.
One way ANOVA of quantitative immunoblot analyses of cerebellar lysates revealed a significant reduction of CNPase in juvenile and young adult Cx47M282T/M282T mice (P10: 73±28%, n = 5, p<0.001; P16: 76±42%, n = 5, p<0.05 and P40: 84±17%, n = 5, p<0.05), while Cx47+/M282T mice displayed a significant reduction of CNPase levels to 67±45%, n = 5, p<0.05 only at P16, compared to wildtype littermates (Figure 10A, B and E). Analyses on lysates obtaind from P28 mice revealed levels of CNPase for both tansgenic genotypes which were not significantly altered compared to wildtype littermates (Cx47+/M282T: 119±39%, n = 3, p = 0.26 and Cx47M282T/M282T: 115±37%, n = 3, p = 0.2). Immunoblot analyses on cerebellar lysates obtained from P90 Cx47+/M282T and Cx47M282T/M282T mice revealed significantly elevated expression of CNPase with a mean level of 181±35%, n = 5, p<0.001, for Cx47+/M282T mice and 160±49%, n = 5, p<0.001, for Cx47M282T/M282T mice in comparison to wildtype animals (100%).
Even more pronounced, expression of MBP was significantly diminished in both Cx47+/M282T and Cx47M282T/M282T mice on days P10, P16, P28 and P40 (Figure 10C–E), as compared to wildtype littermates. This reduction was particularly obvious in P10 Cx47M282T/M282T mice (10±10%, n = 5, p<0.001) and in P10 Cx47+/M282T mice (13±10%, n = 5, p<0.001). Sixteen day-old heterozygous transgenic mice showed less severe but significant MBP reduction to 75±11% (n = 5, p<0.001) and homozygous mCx47M282T expressing mice still had intensly reduced MBP levels to 39±17% (n = 5, p<0.001). Similar results were observed for cerebella of 28-day-old mice with a mean reduction of MBP expression to 61±7% (n = 3, p<0.05) in Cx47+/M282T mice and to 47±22% (n = 3, p<0.001) in cerebella obtained from Cx47M282T/M282T mice. Although the MBP levels were still significantly reduced, the expression almost reached wildtype levels in lysates obtained from 40-day-old Cx47+/M282T mice (92±6%, n = 5, p<0.05) and Cx47M282T/M282T mice (84±21%, n = 5, p<0.05). After three months of postnatal development (P90) MBP expression reached wildtype levels in cerebella of Cx47M282T/M282T animals (97±39%, n = 5, p = 0.83), while beeing significantly elevated in Cx47+/M282T mice at the same developmental stage (145±37%, n = 5, p<0.001).
These data illustrate reduced formation of myelin during adolescence in cerebella of mCx47M282T expressing mice, which is compensated during adulthood.
Deletion of Oligodendrocytic Cx32 in Homozygous Cx47M282T/M282T Mice Results in Severe Myelin Defects, Astrogliosis, and Microglial Activation
Mice deficient for both Cx47 and Cx32 (Cx47−/−/Cx32−/−) display severe myelin malformations and die on average on day 51 . In order to analyze whether mCx47M282T expression is sufficient for proper myelin maintenance or leads to malformations in accordance with Cx47−/−/Cx32−/− mice, we crossbred Cx47M282T/M282T male and Cx47+/M282T/Cx32+/− female mice to obtain Cx47M282T/M282T/Cx32Y/− male mice. These animals were Cx32-deprived and expressed the mCx47M282T mutation homozygously. Like Cx47−/−/Cx32−/− mice, adult Cx47M282T/M282TCx32Y/− displayed severe CNS myelin defects. Immunoblot analyses of cerebellar lysates obtained from P90 Cx47M282T/M282TCx32Y/− mice revealed a significant MBP decrease to residual 11.7±7.3% expression compared to Cx47+/+ mice, while CNPase expression was not significantly altered (Figure 10A, 10C and 10E). Furthermore, histochemical analysis yielded only faint MBP signals while increased GFAP and Iba1 expression was obvious in the cerebellar white matter of these mice (Figure 9M, 9N, and 9O). Only three out of eight animals reached three months of age but displayed severe motor impairment. Death of Cx47M282T/M282TCx32Y/− mice began at the age of 42 days. All dying animals displayed pronounced ataxia one to two days before death. Cx47+/M282TCx32Y/− littermates did not die and displayed staining patterns similar to Cx47+/M282T mice (Figure 9J, 9K, and 9L). These data further illustrate that the loss of Cx47 function in vivo is caused by the M282T missense mutation.
Delayed Myelin Formation in Homozygous Cx47M282T/M282T Mice Is Caused by Loss of Cx47 Function In Vivo
Here we have analyzed phenotypic abnormalities of a new transgenic mouse line, carrying a - loss of function - point mutation which leads to human inherited PMLD1. We decided to introduce only the M282T missense mutation into the mouse Cx47 gene, in order to avoid side effects of other amino acid differences between mouse and human Cx47 proteins.
Expression of the mCx47M282T missense mutation, whose orthologous hCx47M283T counterpart was homozygously found in patients, results in a complex but variable neuropathologic phenotype in juvenile, homozygous Cx47M282T mice.
Cx47 deficiency as well as homozygous Cx47M282T expression leads to similar phenotypes in mice, suggesting that the point mutation of Cx47 results in loss of function proteins in vivo. Accordingly, biocytin injections into corpus callosum oligodendrocytes participating in glial networks revealed a 88% decrease in number of coupled cells in Cx47M282T/M282T P10–P15 mice which was very similar to the 85% reduction observed with Cx47−/− mice. Furthermore, like Cx47 deficiency, homozygous Cx47M282T expression caused a significant reduction of the CNPase- and GFAP-negative population of coupled cells within panglial networks. We have previously characterized the majority of this cell population as oligodendrocyte precursors by expression of Olig2, a marker for both immature and mature oligodendrocytes and by activity of the NG2 promoter .
Immunofluorescence analyses revealed only few Cx47 positive puncta in brain slices of Cx47M282T/M282T mice, although the ß-galactosidase reporter protein, which is encoded by the same bicystronic mRNA was robustly expressed. Loss of mutant protein expression due to the bicistronic mRNA construct carrying IRES LacZ, in addition to the Cx47M282T coding sequence was ruled out by immunoprecipitation and subsequent detection via immunoblot. Furthermore, the IRES was introduced 87 nucleotides downstream of the first and 79 nucleotides upstream the second cistron to achieve optimal expression of both coding sequences and similar constructs did not result in loss of expression in recently published mouse lines –.
Cell culture experiments revealed that transfectants expressing different Cx47 missense PMLD1 mutations showed accumulation in the endoplasmatic reticulum (ER) of most mutant connexins. This resulted in loss of punctate immunostaining in the plasma membrane and loss of channel function , . In addition to ER retention, Cx47M283T connexins were occasionally located at the plasma membrane in HeLa cells . We obtained similar results by expression of the orthologous mCx47M282T protein in HeLa cells (data not shown). However, we could not identify intracellular accumulations of the mutant protein in vivo and immunosignals in the plasma membrane were very rare in homozygous mice. This could be caused by attenuated signals due to trafficking abnormalities and dispersal of Cx47 connexons or by rapid degradation of the mutant protein, possibly ER associated .
Thus, loss of Cx47 function may be due to degradation, rapid internalization and closure of gap junction channels. As a first step to clarify this issue, quantitative Cx47 immunoblots are needed but all currently available antibodies yield prominent unspecific signals in Cx47 deficient brain lysates .
Functional Implications of Cx47 Channels for Myelin Development and Maintenance
Expression of connexins was shown to be critical for cell migration in the CNS  but homozygous expression of the mutant mCx47M282T did not alter the typical distribution pattern of oligodendrocytes during brain development. On the other hand, ten-day-old homozygous mCx47M282T mice displayed a significant reduction of CNPase expression by 28% and more diminished MBP levels (by 90%), whereas 90-day-old mCx47M282T expressing mice showed increased levels of CNPase and almost normal levels of MBP. CNP expression appears early during oligodendrocyte differentiation compared to MBP which indicates mature oligodendrocytes in vivo , . Thus, our data support the notion that Cx47 function in developing oligodendrocytes is needed for regular oligodendrocyte development and proper timing of myelination rather than for oligodendrocyte migration.
Since outright degenerations of white matter as described in Figure 4 are comparatively rare and appear to follow a highly focal distribution, it is unlikely that they contribute to any major degree to the functional alterations seen in these mice. Rather, they may be seen as reflecting local transport imbalances surpassing a critical lethal threshold, while the functional deficits are caused by more generalized transport deficiencies. This view is in line with data from heterozygous mice, in which these degenerative effects are largely absent despite their functional impairments.
Gap junctional conduits couple apposed cells and may form reflexive channels that connect myelin sheaths in oligodendrocytes and Schwann cells , . Panglial networks built by astrocytic and oligodendrocytic gap junctions are considerd to play a key role in spatial K+ siphoning after neuronal activity –. Furthermore, gap junctional communication may also be needed to provide oligodendrocytes with metabolites in particular during differentiation and myelin formation. Insufficient supply of metabolites such as glucose, ATP, and possibly N-acetylaspartate (NAA, 173 Da molecular mass) due to loss of Cx47 channel function is likely to play an important role for the hypomyelinating phenotype of Cx47M282T expressing mice and may be the cause of PMLD1 in humans. Increased levels of NAA represent a typical feature of Canavan Disease, a fatal dysmyelinating disorder caused by mutations of the oligodendrocytic enzyme aspartoacylase (ASPA) . Most children with Canavan disease die in the first decade of life, while mice with loss of Aspa function are able to survive beyond 12 months but display progressive vacuolation in myelin starting around P14 , . PMLD patients showed normal to slightly elevated NAA levels but the N-acetylaspartylglutamate (NAAG) level is increased in the cerebral spinal fluid of PMLD patients harbouring Cx47 mutations , , . NAAG is released by neurons under depolarizing conditions and degraded by the astrocytic enzyme glutamate carboxypeptidase II (GCP II) to glutamate and NAA , . Intraastrocytic NAA may be transported to oligodendrocytes via gap junction channels where it is cleaved by ASPA to aspartate and acetate that may be used subsequently for myelin lipid synthesis . Investigations on lipid composition, NAA, NAAG and aspartate levels in myelin and CSF of Cx47−/−, Cx47M282T/M282T and Cx47M282T/M282T/Cx32−/− mice should clarify whether these metabolites play a major role in PMLD1.
Besides loss of channel function, loss of intracellular protein interaction may also be relevant for the phenotype of Cx47M282T expressing mice and for PMLD. Cx47 was shown to interact with the tight junction adaptor protein zonula occludens 1 (ZO-1), the Y-box transcription factor zonula occludens 1 associated nucleic acid binding protein (ZONAB) which regulates expression of the proliferating cell nuclear antigen (PCNA), cyclin D1 and ErbB-2. –. Interaction of ZONAB and ZO-1 is associated with the transition from a proliferative to a differentiated state of epithelial cells , . In Cx47 deficient mice punctate staining for ZONAB is lost from oligodendrocyte cell somata while ZO-1 signals remain . Analyses on interactions of these proteins with the mutant Cx47M282T using this mouse model will help to gain further insight into intracellular mechanisms which might be influenced by the disease causing mutation.
Cx32 Expression Largely Compensates for the Loss of Cx47 Protein Function in Adult Cx47M282T/M282T Mice
Given that myelination in mutant mice was largely coequal to wildtype mice six weeks after birth, other oligodendrocytic connexins like Cx29 or Cx32 can probably account for compensatory effects in mice.
In normaly developed myelin Cx29 is not localized at oligodendrocyte somata but mainly at the periaxonal space and was recently shown to be incapable of forming functional intercellular gap junction channels , , , . This indicates a distinct role of Cx29 in myelin function and makes it an improbable candidate for functional redundancy of Cx47 channels.
Mice deficient for both Cx47 and Cx32 (Cx47−/−/Cx32−/−) showed severe myelin abnormalities and premature death ,  suggesting functional redundancy of both connexins. This led to the speculation that mutations of Cx47 might lead to a detrimental gain of function and inhibition of Cx32 gap junctional channels .
Although homozygous Cx47M282T expression results in diminished or total loss of Cx47 gap junction channel function, it does, like Cx47 deficiency, not lead to a complete inhibition of interoligodendrocytic coupling as recently described for Cx47−/−/Cx32−/− mice . Furthermore, death of Cx47M282T/M282T/Cx32−/− animals began 42 days after birth and 90-day-old Cx47M282T/M282T/Cx32−/− mice displayed severe motor impairment, myelin malformations, vacuolation, pronounced astrogliosis and increased Iba1 expression, whereas P90 Cx47M282T/M282T mice showed minor affected myelin in the cerebellum. These data further corroborate that the M282T missense mutation results in loss of Cx47 channel function and underline the common role of Cx32 and Cx47 channels for myelin maintenance. In addition, these data show that Cx47M282T does not have a transdominant negative effect on Cx32 function in vivo.
Detailed immunofluorescence analyses have revealed a drafmatic increase of Cx32 levels along myelinated fibers in the CNS of Cx47−/− mice . It seems probable that increased Cx32 expression or altered Cx32 channel localization can account for loss of Cx47 function compensation in Cx47M282T/M282T and Cx47 null mice but not in human PMLD patients.
Heterozygous Cx47+/M282T Mice Show Unexpected Phenotypic Abnormalities
Although PMLD1 is a recessive disease, heterozygous mCx47M282T expressing mice revealed an unexpected CNS phenotype. MBP expression was decreased, accompanied by mild astrogliosis in cerebella of ten-day-old mice. Furthermore, the number of oligodendrocytes forming networks was significantly reduced in heterozygous mice which was not detected in Cx47M282T/M282T or Cx47 null mice. Compared to wildtype littermates, adult Cx47+/M282T but not Cx47M282T/M282T mice showed significantly decreased locomotion, running speed and reduced rearing behavior in the open field test, but no significant alterations in the rotarod assay suggesting impaired neuronal function in motor circuits, independent of a cerebellar phenotype. Immunofluorescence analyses revealed a reduction of Cx47 positive puncta in myelin of Cx47+/M282T mice and the number of oligodendrocytes forming intercellular networks was also reduced in these mice. This reduction may have caused the mild myelin abnormalities and alterations in intercellular coupling found in young heterozygous mice. In contrast to Cx47M282T/M28T mice, high-resolution light microscopy based upon 1 µm thin sections did not reveal lesions in the cerebellum and at best very minor alterations in the optic fascicle. These findings indicate that the functional alterations seen in heterozygous mice are unrelated to myelin degeneration.
Furthermore, Cx47+/M282T/Cx32−/− mice did not die during adolescence and did not show the strong phenotype observed with Cx47M282T/M282T/Cx32−/− and Cx47−/−/Cx32−/− mice. This indicates that residual expression of wildtype Cx47 protein is sufficient to prevent early death in Cx47+/M282T/Cx32−/− mice, in accordance with recessiveness of human PMLD1.
The cause of the phenotypic abnormalities found in heterozygous mice is still enigmatic, but they suggest a gain of detrimental function by heterozygous Cx47M282T expression, possibly due to inhibited or disturbed adapter protein interaction or hemichannel dysfunction . Furthermore, the phenotypes observed with heterozygous and homozygous animals were not completely congruous and some abnormalities aggravated with heterozygous expression. This suggests that compensatory effects in homozygous mice are lacking in heterozygous mice, at least in distinct cells.
Young Homozygous Cx47M282T/M282T Mice As a Model Organism for PMLD1
The course of PMLD1 is progressive in humans in contrast to myelin pathology in Cx47M282T/M282T and Cx47−/− mice. One major difference between mouse and human CNS is the higher portion of white matter in the human brain. While in humans more than 50% of the volume consists of white matter, in the mouse it is only around 10%. The increased number of oligodendrocytes and their relatively extended distance to blood vessels may be one reason for the higher sensibility of the human brain regarding loss of Cx47 function. Furthermore, previous studies have demonstrated the strong ability of the mouse CNS to efficiently compensate for loss of myelin proteins e.g. PLP1 and Nogo-A, MAG or complete elimination of oligodendrocytes during the first weeks of postnatal life –. Cx47M282T/M282T and Cx47−/− mice apparently compensate for loss of Cx47 function within the critical time interval before axonal loss occurs .
Altogether, our results support the notion that loss of Cx47 channel function causes PMLD1. Furthermore, we consider young homozygous Cx47M282T mice, although displaying only transient myelin malformation, as a suitable mouse model to gain closer insights in the mechanisms that lead to inherited human PMLD1.
Materials and Methods
All mice used in this study were kept under standard housing conditions with a 12 h/12 h dark–light cycle and with food and water ad libitum. All experiments were carried out in accordance with local and state regulations for research with animals. All animals investigated harboured at least 96% C57BL/6 genetic background.
Cloning of the mCx47M282T Targeting Vector
The hCx47M283T mutation from a human patient  was inserted by PCR mutagenesis in the orthologous mouse gene resulting in the mCx47M282T mutation, cloned into the pBluescript vector and sequenced in both directions by LGC Genomics (Berlin, Germany). The mutated gene was cloned into a vector containing the IRES and the nls-LacZ cassettes by BclI/HindIII and NsiI digestions and subsequent ligation of blunted ends. The IRES sequence (Clontech Laboratories, CA, USA) was cloned by SmaI digestion from IRES_pBluescript , into pBS_nls_LacZpA  digested with HindIII and subsequent blunt end generation by Klenow polymerase fill in.
The 17.6 kb targeting vector included two homologous regions with a 4667 bp 5′ intron fragment upstream and a 2479 bp 3′ fragment downstream the Cx47 coding DNA. The neomycin selection cassette including the phospoglycerate kinase promoter was flanked by frt sites and cloned into the 3′ homologous region downstream of the Cx47 polyA signal by SalI/XhoI ligation.
The final vector was partially sequenced by LGC Genomics (Berlin, Germany) after restriction analysis. The functionality of the frt sites was verified by transformation into Flp recombinase expressing E. coli bacteria . The functionality of the mCx47M282T-IRES-nls_LacZ construct was tested in HeLa cells (not shown).
Screening of ES Cell Clones for Homologous Recombination
ES cell culture and transfection were performed as described previously . The targeting vector DNA (200 mg) was linearized by SalI digestion prior to transfection. Neomycin resistant ES cell clones were screened for homologous recombination by PCR using an external primer specific to the Cx47 3′ region (Cx47-3-rev: CCA GGA TTC ATG TGA AGG AGA AGG G) and an internal primer specific to the neomycin resistance cassette (primer C1: CTC TGA GCC CAG AAA GCG AAG GAG). To exclude clones in which recombination had occurred partially, a second PCR analysis was performed with cells positive in the first one. Here, we used primers annealing in the coding region of Cx47 (primer B1: GAG GAG CGA GCG GAG GAT GTG GCT G and primer B2: GTG GCG CTG CCG GTT CCG GAA GCT AG) which flanked the BsmBI restriction site that was introduced by the mutation of the Cx47 gene. BsmBI digestion of the 700 bp PCR fragments yieded additional 350 bp fragments which indicated integration of DNA coding for the mutant mCx47M282T. Homologous recombined ES cell clones were subsequently confirmed by Southern blot hybridization. Therefore, DNA from the PCR-positive clones was digested with BamHI or EcoRV and DNA fragments were separated via agarose gel electrophoresis. After blotting onto Hybond N+ membranes (Amersham Biosciences, Buck, UK) and ultraviolet crosslinking for fixation, hybridization was performed under stringent conditions using the Quick Hyb solution (Stratagene, La Jolla, CA, USA) at 68°C for 1.5 h. A 454 bp BglII fragment was used as a 5′ external probe and hybridized with BamHI digested DNA fragments. EcoRV digested DNA was hybridized with an 824 bp 3′ external probe generated by BamHI/XmnI digestion and with a 624 bp HpaI Fragment obtained from the LacZ coding region serving as an internal probe.
Generation and Genotyping of the mCx47M282T Mice
The homologously recombined ES cell clones were injected into C57BL/6 blastocysts, as described previously . Blastocyst injections of ES cells resulted in fur-color chimeric mice. Breeding of chimeric mice with C57BL/6 mice yielded agouti offspring and germline transmission of the recombinant allele was checked by PCR analyses of isolated tail DNA. Heterozygous Cx47+/M282Tneo mice were crossed to hACTB:FLPe mice expressing the Flp-recombinase and litters were backcrossed to C57Bl/6 mice to generate Cx47+/M282T mice. The heterozygous Cx47+/M282T mice were backcrossed with C57BL/6 mice to increase the C57BL/6 genetic background. Genotyping of mice was performed by three primer PCR (primer A1: GCA GCA GAG ACG GCA AGG CCA CC, primer AC2: CCG GTC GCT ACC ATT ACC AGT TGG and primer A3: CAG AGA GAG GAG CTG TTC TTG GTC C) and deletion of the frt site flanked neomycin resistance cassette was verified by PCR using primer C2: CTC AGC TGC AGT AAG GGA TCT CTC G, primer C1 and primer AC2 (described above). Presence of the mutation was verified by PCR and subsequent BsmBI digestion as described for screening of ES cell clones. The different allelic variants were further verified by Southern blot analyses on MfeI digested DNA and hybridization with an 845 bp EcoRI/XhoI fragment as a 3′ internal probe.
β-Galactosidase Staining and Combined Immunolabelling
Mice were killed by injecting an overdose of anesthetic (combination of ketamin hydrochloride and xylazine hydrochloride) intraperitoneally and subsequent transcardially perfusion with 40 ml phosphate-buffered saline (PBS) followed by 25 ml 2% phosphate-buffered formaldehyde solution (Roti-Histofix; Roth, Karlsruhe, Germany) containing 0.2% glutaraldehyde. Tissues of interest were dissected from the mice and postfixed for 24 h at 4°C. 50 µm sagittal vibratome (VT 1200 S, Leica, Wetzlar, Germany) sections were obtained from brains of Cx47M282T/M282T mice for investigation of development-dependent LacZ expression. For immunohistochemistry combined with β-gal staining samples were cryoprotected with 30% sucrose in PBS over night and 40 µm sections were cut with a cryostat (Microm, Walldorf, Germany) and collected on SuperFrost Ultra Plus slides (Menzel, Braunschweig, Germany). β-Gal staining was performed using the substrate 5-bromo-4-chloro-3-indolyl-b-galactoside (X-Gal) as previously described . For doublelabeling immunohistochemical analyses, sections were stained overnight with X-Gal, exposed to PBS containing 0.1% H2O2 and 10% methanol for 20 min, blocked in M.O.M. reagent (Vector Laboratories, Burlingame, CA, USA) and incubated over night at 4°C with primary antibodies in PBS containing 4% BSA. As primary antibodies monoclonal mouse anti-neuronal nuclei (NeuN; 1∶100, Chemicon, Millipore GmbH, Schwalbach/Ts., Germany), monoclonal mouse anti-CNPase (1∶200, Sternberger Monoclonals) and monoclonal mouse anti-GFAP (1∶400, Sigma-Aldrich) were used. Immunohistochemical analyses were performed using the M.O.M. kit, according to manufacturer's instructions. Development of the peroxidase reaction was carried out using 3,3′-diaminobenzidine tetrahydrochloride (Sigma-Aldrich) as a substrate. Slices were air dried and mounted with Entellan (Merck Chemicals, Darmstadt, Germany).
For double immunofluorescence labelling mice were transcardially perfused with PBS containing 1% formaldehyde and 0.1% picric acid, and brains were postfixed in 1% phosphate buffered formaldeyde solution for 2 h and cryoprotected with 30% sucrose in PBS over night. 16 µm cryosections were blocked with TBS (50 mM Tris, 150 mM NaCl, pH 7.5) containing 0.3% Triton X-100 and 5% NGS for 1 h at room temperature. Sections were incubated with both primary antibodies: mouse monoclonal anti-Cx47 (Zymed, 1∶250) and polyclonal rabbit anti-β-gal (ICN, 1∶500) at 4°C over night, washed with TBST (50 mM Tris, 150 mM NaCl, pH 7.5, 0.1% Triton X-100) and incubated for 1 h with appropriate goat polyclonal secondary antibodies conjugated to Alexa-488 and Alexa-594 (1∶500, Invitrogen, Karlsruhe, Germany) diluted in TBS containing 0.3% Triton X-100 and 5% NGS. After TBS washes, sections were mounted with PermaFluor (Thermo Fisher scientific, Waltham, MA, USA) and Images were taken with a Laser Scanning Microscope (LSM 510, Zeiss, Germany).
Dye Coupling in Corpus Callosum Slices
Dye coupling experiments were performed in parallel with experiments previously described  and we shared the controls between these two studies. Acute coronal brain slices containing the corpus callosum were prepared from postnatal days (P) 10–15 mice as previously described . For patch clamp recordings slices were placed in a recording chamber and perfused continuously with artificial cerebrospinal fluid (aCSF) composed of (in mM): NaCl 134; KCl 2.5; MgCl2 1.3; CaCl2 2; K2HPO4 1.25; NaHCO3 26; D-glucose 10 and saturated with carbogen (95% O2, 5% CO2) to a pH of 7.4 at room temperature. Patch clamp recordings were performed as previously described . Pipettes had a resistance ranging from 3 to 7 MΩ when filled with an intracellular solution containing (in mM): NaCl 4; KCl 120; MgCl2 4; CaCl2 0.5; Hepes 10; EGTA 5; D-glucose 5; 0.5% biocytin at pH 7.4. Alexa Fluor 594 (10 µg/ml, Invitrogen, Karlsruhe, Germany) was added to the pipette solution to confirm intracellular access. To improve voltage-clamp control, capacitance was compensated by TIDA software (HEKA Elektronik, Lambrecht, Germany). In each individual slice only a single cell was filled via the patch pipette during whole-cell recordings (20 min) . Only cells with stable input resistance over the 20 min period were considered for data analysis. During recording, the membrane was continuously de- and hyperpolarized between −170 and + 50 mV from a holding potential of −70 mV (10 mV steps, 50 ms). Current signals were amplified (EPC 9/2 or EPC10 amplifiers, HEKA), filtered (3 kHz), sampled (5 kHz), and monitored with TIDA software (HEKA).
Immunohistochemistry following Dye Coupling Experiments
After recording, slices were fixed and processed for biocytin visualization with fluorochrome conjugated streptavidin combined with immunostaining for the oligodendrocyte marker CNPase and the astrocytic marker GFAP, as previously described . Cy3-conjugated streptavidin (1∶200, Jackson ImmunoResearch/Dianova, Hamburg, Germany), mouse anti-CNPase (1∶200, Covance/HISS Diagnostic GmbH, Freiburg, Germany) and rabbit polyclonal anti-GFAP (1∶1.000, DAKO, Hamburg, Germany) were used. Primary antibodies were visualized by application of FITC-conjugated donkey anti-mouse IgG (1∶200) and Cy5-conjugated donkey anti-rabbit IgG (1∶200) or by FITC-conjugated donkey anti-chicken IgG (1∶200, secondary antibodies were purchased at Jackson ImmunoResearch/Dianova), respectively. No unspecific cross reaction between secondary antibodies was observed. Images were acquired by confocal microscopy (Leica TCS SP5, Leica, Solms, Germany) with Leica software (LAS AF Lite).
Evaluation of Dye Coupling
Electrophysiological data were analyzed and plotted using TIDA and Origin (MicroCal, Northampton, Massachusetts). Biocytin filled cells were counted on sequential confocal stacks (0.2–0.8 µm steps) of the 110 µm thick slices with Image-Pro plus (MediaCybernetics, L.P., Bethseda, MD, USA). The maximum extent of tracer spread, defined as the largest distance between two somata within a network, was measured with the same software used for image acquisition. Statistic analysis was performed with SPSS 11.5 for Windows (SPSS Inc., Chicago, Illinois). The cohort of controls used was the same as previously published since the dye coupling experiments described here were performed in parallel with the former study . Differences between groups were evaluated with the Kruskal-Wallis nonparametric test followed by Mann-Whitney U-test for two independent samples, Bonferroni corrected for n-pair comparisons. All values are expressed as median, 25th and 75th percentiles. Values of specific glial cell types are given as percentage of the number of biocytin-positve cells per network. For comparisons between groups, the number of oligodendrocytes forming networks was evaluated with Chi Square-test. Data regarding the extent of tracer spread are expressed as mean ± standard deviation (SD) and were analyzed with one-way ANOVA, followed by Bonferroni post hoc analysis. P-values of <0.05 were considered statistically significant.
Immunoblot and Cx47 Immunoprecipitation
Mice were killed by cervical dislocation and whole brain or cerebella were quickly dissected out and flash frozen in liquid nitrogen. Tissues were stored at −80°C until extraction in homogenization buffer (20 mM Tris, 1% Triton X-100, 140 mM NaCl, 10% glycerol, 1 mM EGTA, 1.5 mM MgCl2, pH 8.0) containing protease inhibitors (Complete Mini; Roche Diagnostics). The samples were homogenized on ice with a glas pestle and subsequently sonicated two times for 15 s. After centrifugation for 15 min at 10.000 g and 4°C, the supernatant was retrieved in new 1,5 ml tubes and kept at −80°C or −20°C. HeLa-Cx47-eGFP  cell lysates were prepared in homogenization buffer. Cultured HeLa cells were harvested and lysed as described previously . Samples were denatured at 60°C for 10 min (Cx47) or 95°C for 5 min containing 1× Laemmli buffer. Proteins (40–100 µg) were separated by electrophoresis on a 10–15% polyacrylamide gel and transferred to Hybond ECL membrane (Amersham Bioscience). Blots were preincubated in a blocking solution of 5% milk powder (MP) in TBST (50 mM Tris, 150 mM NaCl, pH 7.5, 0.1% Tween-20) for 1 h at room temperature, incubated with primary antibodies overnight at room temperature (5 h with anti-Cx47 antibodies) and after three wash steps, with horseradish peroxidase (HRP)-conjugated antibodies (1∶2.000–1∶10.000, Dianova, Hamburg, Germany).
Primary antibodies were polyclonal rat anti-MBP (1∶1.000 in 5% MP, Chemicon, Millipore GmbH, Schwalbach/Ts., Germany), monoclonal mouse anti-CNPase (1∶2.000 in Roti-block (Roth, Karlsruhe, Germany), Sigma-Aldrich) rabbit anti-Cx47 (1∶250 in 4% BSA, No. 36-4700, Invitrogen, Karlsruhe, Germany), rabbit anti β-gal (1∶500 in 5% MP, ICN) and monoclonal mouse anti-tubulin (1∶10.000 in 5% MP, Chemicon, Millipore GmbH, Schwalbach/Ts, Germany).
Protein bands were detected by incubation of the membranes with enhanced chemiluminescence reagents (Amersham Bioscience) and development on X-ray films. Densitometry analysis was performed with E.A.S.Y Win32 software and by normalizing the band intensities to tubulin values.
For immunoprecipitation, 250 µg protein of HeLa-Cx47-eGFP lysate and 600 µg protein obtained from whole brain lysate of wildtype Cx47+/+, Cx47−/− and Cx47M282T/M282T mice were incubated with 85 µl protein A sepharose CL-4B (Amersham Bioscience) each for 3 h at 4°C in TBS and subsequently centrifuged (12.000 g, 4°C, 30 min). Mouse Cx47 antibodies (No. 37-4500, Invitrogen, Karlsruhe, Germany, 2.5 µg) were incubated with 25 µl of protein A-Sepharose (Amersham Biosciences) on ice for 2 h. The precleared lysates were incubated with the protein A-Sepharose antibody complex overnight at 4°C and washed three times with TBST. The proteins were eluted in 18 µl of Laemmli buffer (60°C, 10 min) and separated by electrophoresis as stated above.
Mice were killed with an overdose of chloroform and sequentially perfused via the left ventricle with phosphate buffer with 1% procaine HCL and then 6% glutardialdehyde in phosphate buffer. Tissues of interest were dissected from the mice and embedded in epoxy resin (Epon 812/glycid ether) after postfixation in 2% OsO4. Sections were cut at a thickness of 1 µm heatmounted on aminosilane-coated slides and stained with toluidine blue and pyronin G.
Immunohistochemical Staining on Vibratome Sections
At different ages mice were killed by injecting an overdose of anesthetic intraperitoneally. Mice were transcardially perfused with 40 ml phosphate-buffered saline (PBS) followed by 25 ml phosphate-buffered formaldehyde solution 4% (Roti-Histofix; Roth, Karlsruhe, Germany). The brains were rapidly prepared and postfixed in 2% phosphate-buffered formaldehyde solution for at least 48 h at 4°C. 25 µm vibratome sections were obtained (VT 1200 S, Leica, Wetzlar, Germany) and free floating slices were incubated with 0.1% H2O2 in 10% methanol/PBS (pH 7.4) for 30 min to inhibit endogenous peroxidase activity, washed in PBS and incubated in blocking solution (5% normal goat serum (NGS), 4% BSA, 0.3% Triton X-100, 0.01% NaN3 in PBS) for 2 h at room temperature to avoid unspecific crossreactivity. Primary antibodies were applied in blocking solution for 16 h at room temperature. After washing with 0.2% Triton X-100 in PBS, sections were incubated with the appropriate biotin-conjugated secondary antibody for 2 h at room temperature and washed again. Vectastain Peroxidase ABC reagent (Vector Laboratories, Burlingame, CA, USA) was applied following the manufacturer's protocol. After 30 min incubation in working solution free floating sections were washed in 0.05 M Tris for 20 min and then transfered to bidest for at least 5 min prior to NovaRed (Vector Laboratories, Burlingame, CA, USA) staining. Sections were mounted on glass slides, air dried at 45°C on a slide warmer and coverslipped with Entellan (Merck Chemicals, Darmstadt, Germany). As primary antibodies rat anti-MBP antibodies (1∶750, Chemicon, Millipore GmbH, Schwalbach/Ts, Germany) were used for myelin staining, rabbit polyclonal anti-Iba1 antibodies (1∶750, Wako Chemicals GmbH, Neuss, Germany) were used for staining of microglia and rabbit polyclonal anti-GFAP antibodies (1∶1.000, Dako, Carpinteria, CA USA) were used for detection of astrocytes.
The mice were housed individually in macrolone cages (Type 2, 22×16×13 cm) with metal covers and were given free access to standard rodent diet (Ssniff, Spezialdiäten GmbH, Soest, Germany) and water. They were maintained on a 12 h light-dark schedule with lights on at 7 a.m. and were tested during the light phase between 9 a.m and 6 p.m. All experiments were approved by the North Rhine Westphalia State Authority in accordance with the German legislation on animal experimentation (German Animal Welfare Act, TSchG).
Each animal was subjected to three trials in the open-field with an inter-trial interval of 24 h. The open-field was constructed of grey plexiglas and had the following dimensions: 30 cm (height)×30 cm (length)×30 cm (width). It was illuminated by diffuse white light providing a low illumination density of approximately 10 lux at the center and was placed in a sound-attenuated chamber. A camera mounted above the open field transmitted the digitized image of the open-field to a computer and a VCR. The base area of the open field was subdivided by software into nine equal sized quadrants, providing a 10×10 cm central quadrant and four corner quadrants. Each mouse was individually placed into the central quadrant of the open-field and allowed to freely explore the arena for 10 min. After each trial, the entire apparatus was cleaned with 50% ethanol solution and dried thoroughly. A semi-automated video tracking system (Ethovision Software, Noldus, The Netherlands) was used to quantify the animal's horizontal (the distance travelled in cm, mean running speed in cm/s), and vertical activity (number and duration (s) of rearings on the hind limbs).
Motor Coordination and Balancing on the Rotarod
Motor coordination and balancing was tested with an accelerating rotarod (TSE systems; Bad Homburg, Germany; model no.: 7650). The rotating rod was elevated 10 cm off the floor, had an axis diameter of 3.5 cm and a striated surface made of black rubber. During the acquisition phase, each mouse was given three trials (with an inter-trial interval of ≥25 to control for possible effects of physical exhaustion) per day for three consecutive days. On each trial, the mouse was placed on the inactive drum, with its head pointing towards the direction opposite to that of the rod's motion. The mouse had to move forward on the drum, which was rotating along its vertical axis, in order to avoid falling off. Over a period of 300 s, the rod step-wise accelerated to a speed of 50 rpm. As some mice tend to passively ride around the rod, especially at higher velocities, the duration (s) of active performance until the mouse fell off the drum was registered with a cutoff after 300 s. After retention delay of one week the long-term motor memory of the animals was evaluated during three trials.
Data are presented as mean ± standard error of mean (SEM). Data were analyzed by repeated measures ANOVA and by pre-planned Bonferroni tests between transgenic and wild-type mice. P-values lower than 0.05 were considered statistically significant.
A variable number of blood vessels predominantly in the hippocampal region of Cx47M282T/M282T mice feature perivascular glia being filled with basophilic material or undergoing conspicuous destruction (Cx47+/+ shown in A, C; Cx47M282T/M282T in D and E, arrows pointing to glia cells). Additionally, scattered neurons within the pyramidal cell layer show similar degenerative changes (Cx47+/+ in A, Cx47M282T/M282T in B). Scale bars: A–C, 20 µm; D and E, 10 µm.
We thank Christine Siegmund, Petra Kussmann, and Melanie Jokwitz for their excellent technical assistance in the Bonn laboratory. We thank Dr. B. Uhlenberg for discussions during the early phase of this work.
Conceived and designed the experiments: OT MM AZ ED DH HK KW. Performed the experiments: OT MM AZ DM DH JD. Analyzed the data: OT MM AZ ND DH. Contributed reagents/materials/analysis tools: ED DH HK KW. Wrote the paper: OT MM ED DH KW. Concept, initiation, and organization of the project: KW.
- 1. Uhlenberg B, Schuelke M, Rüschendorf F, Ruf N, Kaindl AM, et al. (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 75: 251–260.
- 2. Bugiani M, Al Shahwan S, Lamantea E, Bizzi A, Bakhsh E, et al. (2006) GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 67: 273–279.
- 3. Wolf NI, Cundall M, Rutland P, Rosser E, Surtees R, et al. (2007) Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics 8: 39–44.
- 4. Salviati L, Trevisson E, Baldoin MC, Toldo I, Sartori S, et al. (2007) A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics 8: 57–60.
- 5. Henneke M, Combes P, Diekmann S, Bertini E, Brockmann K, et al. (2008) GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology 70: 748–754.
- 6. Wang J, Wang H, Wang Y, Chen T, Wu X, et al. (2010) Two novel gap junction protein alpha 12 gene mutations in two Chinese patients with Pelizaeus-Merzbacher-like disease. Brain Dev 32: 236–243.
- 7. Henneke M, Gegner S, Hahn A, Plecko-Startinig B, Weschke B, et al. (2010) Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease. Neurology 74: 1785–1789.
- 8. Diekmann S, Henneke M, Burckhardt BC, Gärtner J (2010) Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction. Eur J Hum Genet 18: 985–992.
- 9. Orthmann-Murphy JL, Salsano E, Abrams CK, Bizzi A, Uziel G, et al. (2009) Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 132: 426–438.
- 10. Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, et al. (2010) GJC2 missense mutations cause human lymphedema. Am J Hum Genet 86: 943–948.
- 11. Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK (2007) Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci 27: 13949–13957.
- 12. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, et al. (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383: 725–737.
- 13. Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, et al. (2003) Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci 23: 4549–4559.
- 14. Nagy JI, Ionescu A, Lynn BD, Rash JE (2003) Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia 44: 205–218.
- 15. Giaume C, Theis M (2010) Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res Rev 63: 160–176.
- 16. Ahn M, Lee J, Gustafsson A, Enriquez A, Lancaster E, et al. (2008) Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct. J Neurosci Res 86: 992–1006.
- 17. Nagy JI, Li X, Rempel J, Stelmack G, Patel D, et al. (2001) Connexin26 in adult rodent central nervous system: demonstration at astrocytic gap junctions and colocalization with connexin30 and connexin43. J Comp Neurol 441: 302–323.
- 18. Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, et al. (2003) Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci 23: 766–776.
- 19. Filippov MA, Hormuzdi SG, Fuchs EC, Monyer H (2003) A reporter allele for investigating connexin 26 gene expression in the mouse brain. Eur J Neurosci 18: 3183–3192.
- 20. Magnotti LM, Goodenough DA, Paul DL (2011) Functional heterotypic interactions between astrocyte and oligodendrocyte connexins. Glia 59: 26–34.
- 21. Altevogt BM, Paul DL (2004) Four classes of intercellular channels between glial cells in the CNS. J Neurosci 24: 4313–4323.
- 22. Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KGV, et al. (2005) Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 136: 65–86.
- 23. Maglione M, Tress O, Haas B, Karram K, Trotter J, et al. (2010) Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia 58: 1104–1117.
- 24. Sargiannidou I, Vavlitou N, Aristodemou S, Hadjisavvas A, Kyriacou K, et al. (2009) Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. J Neurosci 29: 4736–4749.
- 25. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS (2007) Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 34: 629–641.
- 26. Magin TM, McWhir J, Melton DW (1992) A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucleic Acids Res 20: 3795–3796.
- 27. Rodríguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, et al. (2000) High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25: 139–140.
- 28. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS (2004) Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 47: 346–357.
- 29. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871–927.
- 30. Dobrowolski R, Sasse P, Schrickel JW, Watkins M, Kim J, et al. (2008) The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet 17: 539–554.
- 31. Attal J, Théron MC, Houdebine LM (1999) The optimal use of IRES (internal ribosome entry site) in expression vectors. Genet Anal 15: 161–165.
- 32. Schütz M, Scimemi P, Majumder P, De Siati RD, Crispino G, et al. (2010) The human deafness-associated connexin 30 T5M mutation causes mild hearing loss and reduces biochemical coupling among cochlear non-sensory cells in knock-in mice. Hum Mol Genet 19: 4759–4773.
- 33. Meusser B, Hirsch C, Jarosch E, Sommer T (2005) ERAD: the long road to destruction. Nat Cell Biol 7: 766–772.
- 34. Parenti R, Cicirata F, Zappalà A, Catania A, La Delia F, et al. (2010) Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity. Glia 58: 1594–1609.
- 35. Elias LAB, Wang DD, Kriegstein AR (2007) Gap junction adhesion is necessary for radial migration in the neocortex. Nature 448: 901–907.
- 36. Dyer CA (2002) The structure and function of myelin: from inert membrane to perfusion pump. Neurochem Res 27: 1279–1292.
- 37. Tetzlaff W (1982) Tight junction contact events and temporary gap junctions in the sciatic nerve fibres of the chicken during Wallerian degeneration and subsequent regeneration. J Neurocytol 11: 839–858.
- 38. Wallraff A, Köhling R, Heinemann U, Theis M, Willecke K, et al. (2006) The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J Neurosci 26: 5438–5447.
- 39. Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, et al. (2006) Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 26: 10984–10991.
- 40. Rash JE (2009) Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19850107. Accessed 6 June 2010.
- 41. Matalon R, Michals K, Sebesta D, Deanching M, Gashkoff P, et al. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 29: 463–471.
- 42. Matalon R, Michals K, Kaul R (1995) Canavan disease: from spongy degeneration to molecular analysis. J Pediatr 127: 511–517.
- 43. Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, et al. (2008) Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J Neurosci 28: 11537–11549.
- 44. Sartori S, Burlina AB, Salviati L, Trevisson E, Toldo I, et al. (2008) Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene. Eur J Paediatr Neurol 12: 348–350.
- 45. Mochel F, Boildieu N, Barritault J, Sarret C, Eymard-Pierre E, et al. (2010) Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases. Biochim Biophys Acta. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20637281. Accessed 29 July 2010.
- 46. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, et al. (1999) Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415: 52–64.
- 47. Zollinger M, Brauchli-Theotokis J, Gutteck-Amsler U, Do KQ, Streit P, et al. (1994) Release of N-acetylaspartylglutamate from slices of rat cerebellum, striatum, and spinal cord, and the effect of climbing fiber deprivation. J Neurochem 63: 1133–1142.
- 48. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89–131.
- 49. Li X, Ionescu AV, Lynn BD, Lu S, Kamasawa N, et al. (2004) Connexin47, connexin29 and connexin32 co-expression in oligodendrocytes and Cx47 association with zonula occludens-1 (ZO-1) in mouse brain. Neuroscience 126: 611–630.
- 50. Li X, Penes M, Odermatt B, Willecke K, Nagy JI (2008) Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions. Eur J Neurosci 28: 1503–1517.
- 51. Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, et al. (2006) Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 26: 2387–2398.
- 52. Balda MS, Matter K (2000) The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 19: 2024–2033.
- 53. Lima WR, Parreira KS, Devuyst O, Caplanusi A, N'kuli F, et al. (2010) ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 21: 478–488.
- 54. Ebnet K, Suzuki A, Ohno S, Vestweber D (2004) Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117: 19–29.
- 55. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL (2002) Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22: 6458–6470.
- 56. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL (2003) Connexins are critical for normal myelination in the CNS. J Neurosci 23: 5963–5973.
- 57. Klugmann M, Schwab MH, Pühlhofer A, Schneider A, Zimmermann F, et al. (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18: 59–70.
- 58. Pernet V, Joly S, Christ F, Dimou L, Schwab ME (2008) Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci 28: 7435–7444.
- 59. Collin L, Usiello A, Erbs E, Mathis C, Borrelli E (2004) Motor training compensates for cerebellar dysfunctions caused by oligodendrocyte ablation. Proc Natl Acad Sci U S A 101: 325–330.
- 60. Crawford DK, Mangiardi M, Xia X, López-Valdés HE, Tiwari-Woodruff SK (2009) Functional recovery of callosal axons following demyelination: a critical window. Neuroscience 164: 1407–1421.
- 61. Eiberger J, Kibschull M, Strenzke N, Schober A, Büssow H, et al. (2006) Expression pattern and functional characterization of connexin29 in transgenic mice. Glia 53: 601–611.
- 62. Buchholz F, Angrand PO, Stewart AF (1996) A simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs. Nucleic Acids Res 24: 3118–3119.
- 63. Theis M, Magin TM, Plum A, Willecke K (2000) General or cell type-specific deletion and replacement of connexin-coding DNA in the mouse. Methods 20: 205–218.
- 64. Degen J, Meier C, Van Der Giessen RS, Söhl G, Petrasch-Parwez E, et al. (2004) Expression pattern of lacZ reporter gene representing connexin36 in transgenic mice. J Comp Neurol 473: 511–525.
- 65. Haas S, Brockhaus J, Verkhratsky A, Kettenmann H (1996) ATP-induced membrane currents in ameboid microglia acutely isolated from mouse brain slices. Neuroscience 75: 257–261.
- 66. Kressin K, Kuprijanova E, Jabs R, Seifert G, Steinhäuser C (1995) Developmental regulation of Na+ and K+ conductances in glial cells of mouse hippocampal brain slices. Glia 15: 173–187.
- 67. Teubner B, Odermatt B, Guldenagel M, Sohl G, Degen J, et al. (2001) Functional expression of the new gap junction gene connexin47 transcribed in mouse brain and spinal cord neurons. J Neurosci 21: 1117–1126.
- 68. Traub O, Eckert R, Lichtenberg-Fraté H, Elfgang C, Bastide B, et al. (1994) Immunochemical and electrophysiological characterization of murine connexin40 and −43 in mouse tissues and transfected human cells. Eur J Cell Biol 64: 101–112.